Method of therapy and diagnosis of atherosclerosis
AssigneeKaoshiung Medical University
InventorsSuh-Hang JUO, Ku-Chugn Chen, I-Chung Hsieh, Ching-Yu Hu
Life of this patent
Estimating the term…
Loading patent…
AssigneeKaoshiung Medical University
InventorsSuh-Hang JUO, Ku-Chugn Chen, I-Chung Hsieh, Ching-Yu Hu
Estimating the term…
There is provided a method of therapy of atherosclerosis, by providing microRNA let-7g, an analogue thereof or modified let-7g to organisms to inhibit the expression of lectin-like oxidized low density lipoprotein receptor-1 (LOX-1), and the binding of LOX-1 and oxidized low-density lipoprotein (oxLDL), so as to block the pathogenesis of atherosclerosis. Also, a method of diagnosis of atherosclerosis comprises determining the levels of microRNA let-7g in serum or plasma samples of organisms, in which the levels of microRNA let-7g is estimated in individuals with atherosclerosis as compared to individuals without atherosclerosis.
A method of therapy of atherosclerosis, by providing microRNA let-7g, an analogue thereof or modified let-7g to organisms to inhibit the expression of lectin-like oxidized low density lipoprotein receptor-1 (LOX-1), as well as the binding of lectin-like oxidized low density lipoprotein receptor-1 and oxidized low-density lipoprotein (oxLDL).
An active substance of medication for atherosclerosis comprising microRNA let-7g, an analogue thereof or modified let-7g.
A method of diagnosis of atherosclerosis, comprising determining the levels of microRNA let-7g in serum or plasma samples of organisms, in which the levels of microRNA let-7g is estimated in individuals with atherosclerosis as compared to individuals without atherosclerosis.
Dependencies are inferred from the claim text.